Quest Diagnostics Incorporated (DGX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Quest Diagnostics Incorporated (DGX) has a cash flow conversion efficiency ratio of 0.036x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($278.00 Million) by net assets ($7.67 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Quest Diagnostics Incorporated (DGX) net asset quality to measure how much of total assets are equity-financed.
Quest Diagnostics Incorporated - Cash Flow Conversion Efficiency Trend (1996–2025)
This chart illustrates how Quest Diagnostics Incorporated's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check DGX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quest Diagnostics Incorporated Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Quest Diagnostics Incorporated ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yihai Kerry Arawana Holdings Co Ltd
SHE:300999
|
0.137x |
|
SK Holdings Co Ltd
KO:034730
|
0.007x |
|
Accelink Technologies Co Ltd
SHE:002281
|
0.114x |
|
BCE Inc
TO:BCE
|
0.084x |
|
Jiangsu Hengli Hydraulic Co Ltd
SHG:601100
|
0.021x |
|
AXIA Energia
NYSE:AXIA
|
0.039x |
|
Hapag Lloyd AG
XETRA:HLAG
|
0.022x |
|
Pan American Silver Corp
TO:PAAS
|
0.069x |
Annual Cash Flow Conversion Efficiency for Quest Diagnostics Incorporated (1996–2025)
The table below shows the annual cash flow conversion efficiency of Quest Diagnostics Incorporated from 1996 to 2025. For the full company profile with market capitalisation and key ratios, see DGX company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.29 Billion | $1.89 Billion | 0.259x | +33.81% |
| 2024-12-31 | $6.90 Billion | $1.33 Billion | 0.193x | -2.40% |
| 2023-12-31 | $6.42 Billion | $1.27 Billion | 0.198x | -30.70% |
| 2022-12-31 | $6.01 Billion | $1.72 Billion | 0.286x | -15.95% |
| 2021-12-31 | $6.56 Billion | $2.23 Billion | 0.340x | +16.96% |
| 2020-12-31 | $6.89 Billion | $2.00 Billion | 0.291x | +34.90% |
| 2019-12-31 | $5.76 Billion | $1.24 Billion | 0.216x | -3.95% |
| 2018-12-31 | $5.34 Billion | $1.20 Billion | 0.225x | -3.78% |
| 2017-12-31 | $5.04 Billion | $1.18 Billion | 0.233x | +3.41% |
| 2016-12-31 | $4.74 Billion | $1.07 Billion | 0.226x | +33.26% |
| 2015-12-31 | $4.78 Billion | $810.00 Million | 0.169x | -21.82% |
| 2014-12-31 | $4.33 Billion | $938.00 Million | 0.217x | +32.00% |
| 2013-12-31 | $3.97 Billion | $652.00 Million | 0.164x | -42.13% |
| 2012-12-31 | $4.19 Billion | $1.19 Billion | 0.284x | +17.65% |
| 2011-12-31 | $3.71 Billion | $895.50 Million | 0.241x | -12.59% |
| 2010-12-31 | $4.05 Billion | $1.12 Billion | 0.276x | +10.91% |
| 2009-12-31 | $4.01 Billion | $997.40 Million | 0.249x | -15.69% |
| 2008-12-31 | $3.60 Billion | $1.06 Billion | 0.295x | +5.76% |
| 2007-12-31 | $3.32 Billion | $926.92 Million | 0.279x | -11.56% |
| 2006-12-31 | $3.02 Billion | $951.90 Million | 0.315x | +2.29% |
| 2005-12-31 | $2.76 Billion | $851.58 Million | 0.308x | -11.69% |
| 2004-12-31 | $2.29 Billion | $798.78 Million | 0.349x | +26.10% |
| 2003-12-31 | $2.39 Billion | $662.80 Million | 0.277x | -17.91% |
| 2002-12-31 | $1.77 Billion | $596.37 Million | 0.337x | -3.30% |
| 2001-12-31 | $1.34 Billion | $465.80 Million | 0.349x | -2.63% |
| 2000-12-31 | $1.03 Billion | $369.45 Million | 0.358x | +23.87% |
| 1999-12-31 | $863.10 Million | $249.50 Million | 0.289x | +16.10% |
| 1998-12-31 | $567.90 Million | $141.40 Million | 0.249x | -23.50% |
| 1997-12-31 | $541.70 Million | $176.30 Million | 0.325x | +298.14% |
| 1996-12-31 | $538.72 Million | $-88.49 Million | -0.164x | -- |
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagn… Read more